Myeloma Therapy
Studies from University of Torino, Division of Hematology in the area of myeloma therapy published
Published in Hospital Business Week, September 16th, 2007
Data detailed in "Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy" have been presented. "Baseline parameters that may be predictive of outcome after thalidomide treatment have been investigated to identify which myeloma patient subgroups will most benefit from this drug. Thalidomide has been used as a salvage regimen at the study institution since 1999," scientists in Turin, Italy report.
"A total of 102 myeloma patients who were diagnosed between January 1999 and February 2005 were evaluable for intention-to-treat analysis; 78 patients received thalidomide (at a dose of 100...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- ACM
ACM Promotes Brent L. Wilde to CFO - Acusis
2007 Pittsburgh 100--Acusis Again Recognized for High Growth Achievement - Acute Myeloid Leukemia
CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia - Aegis
Aegis Selected to Assist Greenville Hospital System in South Carolina in Launching New Employer-Directed Healthcare Initiative - Aetna
Aetna Announces Members of Racial and Ethnic Equality External Advisory Committee - Allegiance, Inc.
Allegiance Helps Eliminate the Ills of Patient Feedback Management for Holy Cross Hospital - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
